Page last updated: 2024-08-23

fazarabine and Leukemia P388

fazarabine has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahluwalia, GS; Barchi, JJ; Cooney, DA; Covey, JM; Gharehbaghi, K; Hochman, I; Jayaram, HN; Paull, KD1
Ahluwalia, GS; Arnold, ST; Balzarini, J; Cohen, MB; Cooney, DA; Dalal, M; Johns, DG; Kang, GJ; McMahon, JB; Wilson, YA1

Other Studies

2 other study(ies) available for fazarabine and Leukemia P388

ArticleYear
Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblasts.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Survival; Deoxycytidine; DNA, Neoplasm; Humans; Leukemia P388; Lymphocytes; Mice; Mice, Inbred Strains; Phosphorylation; Tumor Cells, Cultured

1996
Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: Animals; Azacitidine; Biological Transport; Colonic Neoplasms; Cytidine; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Humans; Leukemia P388; Mice; Phosphorylation

1986